INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28

March 26, 2024

https://www.globenewswire.com/news-release/2024/03/26/2852723/0/en/INmune-Bio-Inc-to-Report-Fourth-Quarter-2023-Financial-Results-and-Provide-a-Corporate-Update-on-Thursday-March-28.html

Management to host conference call and webcast at 4:30 pm ET on that day

Boca Raton, Florida, March 26, 2024 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ:INMB) (the “Company”), a clinical-stage immunology and inflammation company focused on developing treatments that harness a patient’s innate immune system to fight disease, today announced that it will host a conference call on Thursday, March 28, 2024 at 4:30 PM Eastern Time to discuss results for its fourth quarter ended December 31, 2023 and to provide a corporate update.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.